BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
Medical board and malpractice exposure, an honest assessment In a board investigation or malpractice claim, the file you can produce matters more than the evidence base behind the compound
ARA-290 is a "non-hematopoietic" analog of EPO
They say it's a miracle for healing.' This conversation is becoming alarmingly common in my practice
But whether it's right for you isn't a question a website can answer it depends on your labs, your history, and your goals, and that's the first thing we look at in a consultation
Resources: Barbell Medicine coaching and templates: Signal book pre-order: Pontzer et al., Science 2021